Project/Area Number |
16K01850
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Applied health science
|
Research Institution | National Center for Global Health and Medicine |
Principal Investigator |
Yasuda Kazuki 国立研究開発法人国立国際医療研究センター, その他部局等, その他 (80311611)
|
Research Collaborator |
Nammo Takao
Funahashi Nobuaki
|
Project Period (FY) |
2016-04-01 – 2019-03-31
|
Project Status |
Completed (Fiscal Year 2018)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥2,600,000 (Direct Cost: ¥2,000,000、Indirect Cost: ¥600,000)
|
Keywords | NASH / 生活習慣病 / mRNA / 遺伝子発現調節 / クラスター / AKR1B10 / miRNA / 非アルコール性脂肪性肝炎 / マイクロRNA |
Outline of Final Research Achievements |
We performed comprehensive analysis of transcriptome of the liver obtained from Japanese NASH (non-alcoholic steatohepatitis) subjects. Unsupervised two-way cluster analyses revealed that genes with similar function, such as inflammation, lipid metabolism, cell profanation or fibrosis, constituted co-regulated gene clusters, which were quite compatible with “multiple parallel hits hypothesis” of NASH development. We analyzed mechanisms of transcriptional regulation of two interesting genes, AKR1B10 and a novel member of the same family AKR1B15, using human HuH7 cells, and found specific upstream signals for each gene, suggesting complex pathophysiology of NASH.
|
Academic Significance and Societal Importance of the Research Achievements |
NASHは極めて頻度の高い疾患であるだけでなく、肝がんの発生母地として、また心血管病変のハイリスクとして重要であるが、病態の多くが不明で、侵襲的な肝生検以外に確定した診断方法がなく、さらに有効な治療薬もないなど、unmet medical needsの代表的疾患である。本研究は実際のヒト組織を用いてNASHの分子病態を明らかにし、画期的な診断・治療薬の開発への道を開く可能性を秘めた研究である。
|